Shalom Zwiebel: Clinical Practice Evaluating PRP Systems and Supply Partners
Shalom Zwiebel, Clinical Liaison at Renova Wound Care, shared a post on LinkedIn:
“Clinical Practice Evaluating PRP Systems and Supply Partners
As the use of Platelet-Rich Plasma therapy (PRP) continues to expand across wound care, orthopedics, dermatology, and regenerative medicine, the consistency and reliability of PRP preparation systems are essential for achieving predictable clinical outcomes.
Our clinical practice is currently evaluating PRP technologies and supply partners to support ongoing and growing clinical utilization of biologic therapies in patient care.
We are interested in connecting with established manufacturers or authorized distributors that offer:
- Clinically validated PRP preparation systems
- Regulatory-compliant kits and centrifuge platforms
- Consistent platelet concentration and reproducible processing
- Reliable supply chain and clinical support for physician practices
Given the expected clinical volume, we are particularly interested in working with experienced U.S.-based manufacturers or distributors that can support long-term clinical partnerships.
If your organization manufactures or distributes PRP systems, kits, centrifuges, or regenerative medicine technologies, we would welcome the opportunity to learn more about your platform.
Manufacturers or authorized distributors only, please.
Please feel free to reach out via direct message or comment below.”
Stay updated with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers